1. Corporate Officers - O
2. Ocampo Christine

Insider Trading History of Ocampo Christine

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Ocampo Christine since 2005. The trader's CIK number is 1280154. At the time of the last reporting, Ocampo Christine was the Vice President, Fina of Novus Therapeutics, Inc.. (stock ticker symbol NVUS). Also see all insider trading activities at Novus Therapeutics, Inc..

Note that in the past OCAMPO CHRISTINE also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Avanir Pharmaceuticals (AVNR) by Ocampo Christine

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2014	AVNR	0	$0	132,466	$1,352,618	30,000	$101,550
2013	AVNR	0	$0	80,150	$261,844	57,700	$50,776
2012	AVNR	3,000	$7,794	67,845	$234,107	65,000	$34,450
2011	AVNR	0	$0	94,926	$248,435	92,250	$88,560
2010	AVNR	0	$0	104,778	$365,464	75,600	$101,728
2009	AVNR	11,900	$5,117	0	$0	0	$0

Yearly summary of insider trading at Cardiogenesis Corp /ca (CGCP) by Ocampo Christine

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2005	CGCP	20,000	$8,700	0	$0	0	$0

Yearly summary of insider trading at Novus Therapeutics, Inc. (NVUS) by Ocampo Christine

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2017	NVUS	10,010	$99,999	0	$0	0	$0

Insider trading activities at 3 companies by Ocampo Christine:

1. Avanir Pharmaceuticals (AVNR)

2. Cardiogenesis Corp /ca (CGCP)

3. Novus Therapeutics, Inc. (NVUS)

Table 1. Insider trading of Avanir Pharmaceuticals (AVNR) by Ocampo Christine

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2014-12-18	AVNR	Sale	5,780	16.93	97,855
2014-12-16	AVNR	Option Ex	30,000	3.38	101,550
2014-12-16	AVNR	Sale	30,000	16.94	508,200
2014-10-24	AVNR	Sale	2,080	11.81	24,564
2014-09-15	AVNR	Sale	55,000	9.45	519,749
2014-08-26	AVNR	Sale	2,110	6.10	12,871
2014-05-16	AVNR	Sale	11,900	4.88	58,072
2014-05-14	AVNR	Sale	25,596	5.13	131,307
2013-12-18	AVNR	Sale	2,450	2.63	6,445
2013-05-15	AVNR	Option Ex	57,700	.88	50,776
2013-05-15	AVNR	Sale	77,700	3.29	255,399
2012-12-03	AVNR	Sale	2,845	2.55	7,257
2012-09-17	AVNR	Option Ex	65,000	.53	34,450
2012-09-17	AVNR	Sale	65,000	3.49	226,850
2012-03-06	AVNR	Buy	3,000	2.60	7,794
2011-12-02	AVNR	Sale	2,676	2.38	6,371
2011-11-11	AVNR	Option Ex	92,250	.96	88,560
2011-11-11	AVNR	Sale	92,250	2.62	242,064
2010-12-06	AVNR	Sale	13,660	3.79	51,771
2010-12-03	AVNR	Sale	23,350	4.03	94,100
2010-12-02	AVNR	Sale	24,000	4.15	99,600
2010-12-03	AVNR	Option Ex	23,350	1.31	30,588
2010-12-02	AVNR	Option Ex	24,000	1.74	41,760
2010-08-11	AVNR	Option Ex	28,250	1.04	29,380
2010-08-11	AVNR	Sale	28,250	3.10	87,716
2010-03-16	AVNR	Sale	15,518	2.08	32,277
2009-02-24	AVNR	Buy	11,900	.43	5,117

Table 2. Insider trading of Cardiogenesis Corp /ca (CGCP) by Ocampo Christine

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2005-05-19	CGCP	Buy	20,000	.43	8,700

Table 3. Insider trading of Novus Therapeutics, Inc. (NVUS) by Ocampo Christine

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2017-05-10	NVUS	Buy	10,010	9.99	99,999

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ocampo Christine (Vice President, Fina of Novus Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month